Leukoencephalopathy During Daratumumab-Based Therapy: A Case Series of Two Patients with Multiple Myeloma

Leukoencephalopathy in the setting of multiple myeloma (MM) is a rare demyelinating condition, with few reported cases in literature. Daratumumab is a CD38 targeted monoclonal antibody that has been widely used for the management of MM. In the absence of central nervous system (CNS) disease, many me...

Descripción completa

Detalles Bibliográficos
Autores principales: Kareem, Syeda Saba, Viswanathan, Neena, Sahebjam, Solmaz, Tran, Nam D, Gatewood, Tyra, Tobon, Katherine, Baz, Rachid, Piña, Yolanda, Shain, Kenneth H, Mokhtari, Sepideh
Formato: Online Artículo Texto
Lenguaje:English
Publicado: Dove 2022
Materias:
Case Series
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9464026/
https://www.ncbi.nlm.nih.gov/pubmed/36097632
http://dx.doi.org/10.2147/OTT.S365657

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9464026/
https://www.ncbi.nlm.nih.gov/pubmed/36097632
http://dx.doi.org/10.2147/OTT.S365657

Ejemplares similares